Insider buying last 90 days
No open-market insider purchases were filed for CVS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CVS insider filing, plotted on the chart in Gekko.Open CVS in Gekko
NYSE: CVS
CVS Health (CVS) Stock Analysis & Forecast
Nov 4 close
$79.96−11.45 (−12.5%)
Gekko Brief
AI summaryNov 4 closeCVS Health tumbled this week after announcing plans to split into two independent publicly traded companies by the first half of 2028, separating its retail pharmacy business from its healthcare solutions operations, which include Aetna and Caremark. The move came despite a Q3 2026 earnings beat, with actual EPS of $2.09 against an estimate of $1.65, and a raised full-year outlook. Coverage framed the breakup as a strategic reversal intended to let CVS Pharmacy sharpen its front-end focus, including beauty and wellness, while separating the insurance and pharmacy benefit manager operations. Separately, Aetna secured a national in-network agreement with Cerenome for its CNSide diagnostics test.
The stock closed at $79.96, down 12.5% on the day, sitting between its 50-day average of $90.82 and 200-day average of $88.89. Over the past month the shares are down 7.5%, and down 16.9% over three months, though still up 1.9% over the past year. The GekkoIndex reads 69.3, placing CVS in the Accumulation zone, up 9.6 over five days. The price sits 51.2% below Gekko Fair Value of $163.88.
No confirmed next earnings date appears on the calendar. Over the last 30 days, one unusual options signal registered, with call premium of $5,235,184 against put premium of $844,353. Three billionaire holders and one trailblazer holder are noted. All 15 covering analysts rate the stock buy, with a consensus target of $115.52. Seasonally, the next 20 trading days have averaged +0.1% over 5 years, rising in 2 of them, with typical 20-day moves near 5.4%.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
CVS Health price vs fair value
Close $79.96200-day averageGekko Fair Value $163.88
CVS Health quick facts
- Market cap
- $102.3B
- P/E ratio
- 23.3
- Forward P/E
- 10.7
- EPS, TTM
- $3.80
- Revenue, TTM
- $412.6B
- Profit margin
- 1.2%
- Dividend yield
- 2.95%
- Beta
- 0.58
- Volume
- 34.18M avg 9.70M
- 1-year return
- +1.9%
- Typical daily move
- ±3.8%
- Typical 20-day move
- ±5.4%
- 50-day average
- $90.82
- 200-day average
- $88.89
- Next earnings
- —
- Shares outstanding
- 1.28B
CVS Health swing-trade checklist
CVS Health scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendmixed
Averages disagree
Close $79.96 sits between the 50-day ($90.82) and 200-day ($88.89) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
69.3, Accumulation
Reading 69.3 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
51.2% below
Price is 51.2% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneysupportive
Leans bullish
Last 30 days: 1 unusual options signal.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
See earnings - Seasonalitymixed
+0.1% on average
From this point in the calendar, the next 20 trading days averaged +0.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
CVS Health stock chart and price history
CVS Health closed at $79.96 on Nov 4, 2026, +1.9% over the past year, inside a 52-week range of $69.51 to $110.68.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −7.5%
- 3 months
- −16.9%
- 6 months
- −7.9%
- 1 year
- +1.9%
The full CVS chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CVS in Gekko
Follow CVS Health through every session
Put CVS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CVS in GekkoFree for 7 days. No credit card required.
About CVS Health
CVS Health operates in the healthcare space, bringing together insurance, pharmacy management, and drugstore services for consumers and patients. It has become known for offering a wide net of care options, from medical coverage to filling prescriptions and treating people in clinics, online, and in their homes.
The business runs across four segments. One focuses on health insurance coverage, another manages pharmacy benefits and delivers clinical care through virtual visits, home services, and medical clinics. A separate segment handles prescription dispensing at retail pharmacy locations and through infusion services, while the remaining segment covers corporate management and administrative functions.
Stanley P. Goldstein and Ralph Hoagland started the business back in 1963, and it now runs its operations out of Woonsocket, Rhode Island. Shares of CVS Health trade on the NYSE under the ticker CVS.
- Listed
- NYSE
- Sector
- Retail trade
- Industry
- Drugstore chains
- Website
- cvshealth.com
CVS Health GekkoIndex: the smart money zone
CVS Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.3, in the Accumulation zone, up 9.6 points over five sessions.
69.3Accumulation
Up 9.6 points over five sessions, from the Neutral zone.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 39 | +0.9% | +10.2% | ||
| Accumulation (current zone) | 213 | +0.4% | +1.6% | ||
| Neutral | 414 | +0.2% | +0.3% | ||
| Distribution | 30 | −1.1% | −2.8% | ||
| Selling | 1 | Too few readings yet | |||
Average CVS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the CVS price, zone by zone.Track CVS in Gekko
Is CVS Health stock overvalued? Gekko Fair Value
CVS Health trades 51.2% below Gekko Fair Value of $163.88, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what CVS Health shares are worth, recalculated every trading day.
$163.88
Gekko Fair Value, Nov 4, 2026
51.2% Undervalued
At the end of Aug 2026 the price was 15.3% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open CVS in Gekko
CVS Health insider and Congress trading
No open-market insider purchases were filed for CVS Health, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CVS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CVS, plotted on the chart in Gekko.Open CVS in Gekko
Buybacks
CVS Health has been buying back its own shares.
- Bought back, quarter ended Sep 30, 2024
- $1.00M
- As a share of market cap
- 0.00%
- Trailing four quarters
- $3.03B
From company filings.
Unusual options activity last 30 days
1signal, 86% of the flagged premium in calls.
Latest: Bullish flow on Oct 22, $6.08M in unusual premium.
Hedge funds and billionaires quarter ended Jun 30
4of the funds Gekko tracks hold CVS.
0added2opened2trimmed0sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko
CVS Health earnings: next date and track record
CVS Health beat the EPS estimate in 8 of its last 8 reports, moving 6.7% on average across the report.
8 of 8reports beat the EPS estimate
±6.7%average move across the report
5 of 7reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 4, 2026 | $2.09 est $1.65 | $108.4B est $104.7B | — |
| Aug 5, 2026 | $2.58 est $1.87 | $106.1B est $100.0B | −7.9% |
| May 6, 2026 | $2.57 est $2.18 | $100.4B est $94.99B | +8.3% |
| Feb 10, 2026 | $1.09 est $1.00 | $105.7B est $103.7B | +1.6% |
| Oct 29, 2025 | $1.60 est $1.37 | $102.9B est $98.81B | −6.7% |
| Jul 31, 2025 | $1.81 est $1.46 | $98.92B est $94.53B | +0.3% |
| May 1, 2025 | $2.25 est $1.70 | $94.59B est $93.68B | +1.1% |
| Feb 12, 2025 | $1.19 est $0.91 | $97.71B est $97.09B | +20.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
CVS Health stock forecast and analyst price targets
Analysts’ average 12-month price target for CVS Health is $115.52, +44.5% from the last close, from 15 firms rating the stock in the last 90 days.
$115.52consensus 12-month target, +44.5% from the last close
Now $79.96Avg $115.52
Low $107High $123
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Bernstein | $112 | +40.1% |
| Nov 4 | Morgan Stanley | $111 | +38.8% |
| Nov 4 | Barclays | $108 | +35.1% |
| Nov 4 | Evercore ISI | $110 | +37.6% |
| Nov 3 | Wells Fargo | $123 | +53.8% |
+1.6%average 20-day move after past Accumulation readings
+0.1%average move over the next 20 trading days in the last 5 years
±3.8%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
CVS Health seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, CVS Health averaged +0.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.3% | 2 of 5 |
| Next 10 trading days | −0.2% | 2 of 5 |
| Next 15 trading days | +1.2% | 3 of 5 |
| Next 20 trading days | +0.1% | 2 of 5 |
| Next 30 trading days | −2.3% | 2 of 5 |
For scale, CVS’s typical 20-trading-day move in either direction is about 5.4%.
CVS Health market cap and key statistics
CVS Health’s market cap is $102.3B, with a P/E ratio of 23.3 and revenue of $412.6B over the last twelve months.
Valuation
- Market cap
- $102.3B
- P/E ratio
- 23.3
- Forward P/E
- 10.7
- EPS, TTM
- $3.80
- Gekko Fair Value
- $163.88
Trading
- Volume
- 34.18M
- Avg volume, 20 days
- 9.70M
- 52-week high
- $110.68
- 52-week low
- $69.51
- Shares outstanding
- 1.28B
Financials
- Revenue, TTM
- $412.6B
- Profit margin
- 1.2%
- Return on equity
- 6.2%
- Quarterly earnings growth, YoY
- +188.8%
Risk and income
- Beta
- 0.58
- Typical daily move
- ±3.8%
- Typical 20-day move
- ±5.4%
- Dividend yield
- 2.95%
CVS Health stock news this week
Coverage of CVS Health this week reads neutral: 4 positive, 5 neutral and 2 negative headlines.
- Will Beauty and Wellness Have More Space to Shine in a Revamped CVS?Yahoo Finance Singapore, Nov 4
- CVS Health plans to split itself up. Here's why a breakup could make sense nowCNBC, Nov 4
- Wednesday's Final Takeaways: CVS Splitting in Two, ORCL Scraps Tencent DealSchwab Network, Nov 4
- CVS Tumbles 12% on Plan to Split Into Two Companies Despite Earnings Beat; Elevance Health Rises 4%, Cigna Climbs 3%24/7 Wall St., Nov 4
- CVS is splitting into two companies: Healthcare giant's ‘Pharmacy' breakup explainedFast Company, Nov 4
- CVS Health Q3 2026 Earnings Call TranscriptBenzinga, Nov 4
CVS Health peers
CVS Health’s 1 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| GRDNGuardian Pharmacy Services | Neutral | 13.1% above |
A peer links to its own page where one exists.
CVS Health stock FAQ
What is CVS Health’s market cap?
CVS Health’s market cap is $102.3B at the Nov 4, 2026 close of $79.96, with 1.28B shares outstanding. The shares trade on a P/E ratio of 23.3.
What is the CVS Health stock forecast?
The consensus analyst 12-month price target for CVS Health is $115.52, +44.5% from the last close. Of the 15 firms that rated the stock in the last 90 days, 15 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is CVS Health stock overvalued or undervalued?
On Gekko’s estimate CVS Health is undervalued: the Nov 4, 2026 close of $79.96 is 51.2% below Gekko Fair Value of $163.88. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is CVS Health’s 52-week high and low?
CVS Health’s 52-week high is $110.68 and its 52-week low is $69.51; it closed at $79.96 on Nov 4, 2026, +1.9% over the past year. Over the last five years the shares peaked at $111.25 on Feb 8, 2022.
Is CVS Health stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and smart money), 2 as mixed (trend and seasonality). The checklist is a description of current data, not a recommendation.
Is there unusual options activity in CVS Health?
Gekko flagged 1 unusual options signal in CVS Health over the last 30 days, with $5.24M of flagged premium in calls and $844K in puts. The latest, bullish flow, was on Oct 22, 2026 with $6.08M in unusual premium. The signal-by-signal table is in Gekko.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See CVS Health the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.